Home › Funds › Counterpoint Mutual Funds LLC › TXG
Counterpoint Mutual Funds LLC position in TXG
10X GENOMICS INC · Industrials
Counterpoint Mutual Funds LLC reported holding 125,769 shares of TXG (10X GENOMICS INC) in its Q3 2026 13F filing — a position valued at US$11.4M, representing 0.98% of its reported portfolio and ranking #8 among its reported holdings. Counterpoint Mutual Funds LLC has disclosed TXG holdings in 7 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR
How Counterpoint Mutual Funds LLC's TXG position evolved
Counterpoint Mutual Funds LLC first disclosed a stake in TXG in Q3 2023 at 5,177 shares (US$214K). The position peaked in Q3 2026 at 125,769 shares, worth US$11.4M. Across 7 filings, Counterpoint Mutual Funds LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 125,769 shares valued at US$11.4M. Notable position changes include a 52% increase in Q1 2025 (shares rose 33% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 5.18K | $213.55K | New |
| Q2 2024 | 10.86K | $211.25K | New |
| Q4 2024 | 51.66K | $741.81K | New |
| Q1 2025 | 78.52K | $685.51K | Add |
| Q2 2025 | 78.25K | $906.12K | Hold |
| Q3 2025 | 71.40K | $834.64K | Reduce |
| Q3 2026 | 125.77K | $11.36M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TXG and 13F data
TXG (10X GENOMICS INC) is a Industrials company. 39 other funds we track also report a position in TXG — the largest reported positions include ARK Invest (US$383.5M), Quantinno Capital Management LP (US$209.7M), Amova Asset Management Americas, Inc. (US$160.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TXG
- ARK Invest 10.00M sh · $383.52M · Q2 2026
- Quantinno Capital Management LP 5.47M sh · $209.71M · Q2 2026
- Amova Asset Management Americas, Inc. 4.19M sh · $160.74M · Q2 2026
- Casdin Capital 1.05M sh · $40.26M · Q2 2026
- Anomaly Capital Management, LP 867.79K sh · $33.27M · Q2 2026
- Blue Water Life Science Advisors, LP 642.00K sh · $24.61M · Q2 2026
- Freshford Capital Management, LLC 600.42K sh · $23.02M · Q2 2026
- CLOUGH CAPITAL PARTNERS L P 549.97K sh · $21.09M · Q2 2026
More on Counterpoint Mutual Funds LLC
FAQ
How long has Counterpoint Mutual Funds LLC held TXG?
Counterpoint Mutual Funds LLC has disclosed TXG holdings in 7 of the last 13 reported quarters, going back to Q3 2023.
What is Counterpoint Mutual Funds LLC's current position in TXG?
As of Q3 2026, Counterpoint Mutual Funds LLC holds 125.77K shares of TXG (10X GENOMICS INC), valued at $11.36M, representing 0.98% of its reported portfolio and ranking #8.
Has Counterpoint Mutual Funds LLC been buying or selling TXG?
In the latest 13F filing (Q3 2026), Counterpoint Mutual Funds LLC newly opened its position in TXG. The position peaked in Q3 2026 at 125.77K shares.
Which other funds hold TXG?
Other major institutional holders of TXG include ARK Invest, Quantinno Capital Management LP, Amova Asset Management Americas, Inc., among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.